In their discovery of a new way to inhibit formation of HIV’s protease enzyme, scientists may have identified a new drug target, according to new data published in the August 2008 issue of Biopolymers and reported today by ScienceDaily.
Protease is a doughnut-shaped enzyme involved in processing viral proteins and assembling them into new infectious viruses. It is currently the target of a handful of drugs called protease inhibitors, all of which bind to and block the hole in the doughnut shape.
Heather Carlson, PhD, a professor of chemistry at the University of Michigan, and her colleagues used computer models of the protease enzyme to discover a new part of the enzyme’s structure that would be vulnerable to chemical inhibition. They found that before the protease assumes its doughnut shape, two ends have to bind together to close the circle. Where these two flaps join is the site that Carlson’s team chose to focus on.
Using their computer models, they developed a chemical inhibitor that was successful at stopping the two ends from joining and the enzyme from maturing into its final shape. The chemical inhibitor they developed is too weak to work as a drug in the human body, but Carlson’s discovery does offer a potential new target for drug development.
NEW! Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
Previous Comments:
comments 1 - 2 (of 2 total)
pablo, Newport Beach, CA, 2008-06-16 09:46:23
A CURE... A medium to STOP the virus. A Key to disrupting and ultimatelly destroying the virus and render it useless. THAT is what we mostly need. We crave the news of such discovery to be done ASAP. Yes Current drugs are life savers and all but we know little about the long term side effects of such chemicals. Even today, under the "best" prescription of drug treatments. We don't know the long time effects of these. A CURE is desperatelly needed. not another drug...
Nate HJohnson, Cincinnati, 2008-05-21 11:37:37
As a consumer of protease inhibitors since 2 days after their widespread release I have great interest in this new development. I am a member of the AIDS Clinical Trials national consumer board the NCAB and have a keen interest in development of new and less toxic drugs to fight, or erradicate HIV. This is exciting news!
Beth Benne, RN, is HIV negative, but
the virus has impacted her life. She currently supervises a biannual HIV/AIDS awareness week as
the director of the student health center at Pierce College, a
community commuter school in Woodland Hills, California.
Woman of the Month is supported by exclusive advertising from Gilead.
Overheard in the Women's Forum
"I recently met a guy who is negative. I did tell him about my status and he decided to kiss me anyway (we didn't go further than that). But a day later, he called and said that he actually had a mouth ulcer that time when we kissed and he was very worried. Asked if he can get the virus from me that way. For that moment, I felt so insulted and yet I felt so bad. It was my first time having a contact with a "negative" guy."
